MT2022-01

mesenchymal stem cells · Masonic Cancer Center, University of Minnesota

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MT2022-01, covering 2025-05-30 to 2025-05-30. Get the full timeline:

Most recent: Clinical Trial Update: MT2022-01: MSCs for ALD [Phase 1]